Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

ACTA1 Inhibitors

Chemical inhibitors of ACTA1 can disrupt the normal function of actin filaments within cells through various mechanisms, each specific to the chemical's structure and affinity for actin monomers or filaments. Cytochalasins D and B are examples of compounds that bind to the barbed ends of actin filaments, which are the preferred sites for the addition of new actin monomers. By capping these ends, they prevent the elongation of the filaments, effectively stopping the formation of new actin structures. Latrunculin A and Tropodithietic Acid work differently; they sequester actin monomers, thereby inhibiting their polymerization into filaments. This sequestration of G-actin prevents it from being incorporated into filaments, thus halting the dynamic restructuring of the cytoskeleton that is essential for various cellular processes.

Other inhibitors such as Swinholide A, Chondramide, and Mycalolide B target ACTA1 by severing existing filaments and binding to their newly formed ends, preventing re-polymerization and leading to a net decrease in filamentous actin within the cell. Swinholide A, specifically, acts by severing actin filaments and capping the barbed ends. In contrast, Jasplakinolide and Phalloidin stabilize the filaments in their polymerized state. This stabilization, while seemingly counterintuitive, actually inhibits the function of ACTA1 by preventing the necessary turnover and dynamic rearrangement of the actin cytoskeleton. Misakinolide A and Mycalolide B also lead to disassembly of actin filaments, but through sequestering actin monomers, adding another layer of inhibition by reducing the pool of polymerizable actin. Finally, S-Methyl DMAB alters the polymerization properties of actin by modifying the cysteine residues on actin monomers, which can affect filament formation. Pentabromopseudilin indirectly affects ACTA1 function by targeting myosin and inhibiting the actin-myosin interaction, which is crucial for muscle contraction and cellular movement. Each of these compounds, through their unique interactions with ACTA1, serve as powerful tools in dissecting the complex roles of actin in cellular function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$145.00
$442.00
64
(4)

Cytochalasin D binds to the barbed ends of actin filaments, preventing the addition of new monomers. This directly inhibits ACTA1 by preventing actin filament elongation and thus disrupting the dynamics of the actin cytoskeleton.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$260.00
$799.00
36
(2)

Latrunculin A sequesters actin monomers and inhibits their polymerization. By binding to monomeric G-actin, it effectively inhibits ACTA1 from forming filaments, thus disrupting actin cytoskeleton organization and function.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$180.00
$299.00
59
(1)

Jasplakinolide promotes actin filament nucleation and stabilizes the filaments, which paradoxically can result in the inhibition of ACTA1 by preventing the natural turnover of actin filaments essential for cellular processes.

Phalloidin

17466-45-4sc-202763
1 mg
$229.00
33
(1)

Phalloidin binds tightly to F-actin at the interface between actin subunits, stabilizing the filament and preventing its disassembly. This inhibits ACTA1 function by locking actin filaments in a polymerized state, reducing filament turnover.

Cytochalasin B

14930-96-2sc-3519
5 mg
$195.00
19
(1)

Cytochalasin B disrupts actin polymerization by binding to the barbed ends of actin filaments, preventing the addition of actin monomers and thus directly inhibiting the function of ACTA1.